Cargando…

Appropriateness of treatment recommendations for PPI in hospital discharge letters

PURPOSE: The reasons for the dramatic increase in proton pump inhibitors (PPI) prescriptions remain unclear and cannot be explained solely by increased morbidity, new indications or a decrease in alternative medication. Inappropriate use and discharge recommendations in hospitals are considered to b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahrens, Dirk, Chenot, Jean-François, Behrens, Gesa, Grimmsmann, Thomas, Kochen, Michael M.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982961/ https://www.ncbi.nlm.nih.gov/pubmed/20694459 http://dx.doi.org/10.1007/s00228-010-0871-9

Ejemplares similares

Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?
por: Grimmsmann, Thomas, et al.
Publicado: (2011)

The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany
por: Grimmsmann, Thomas, et al.
Publicado: (2020)

Are multidose drug dispensing systems initiated for the appropriate patients?
por: Mertens, Bram J., et al.
Publicado: (2018)

Hospital electronic prescribing system implementation impact on discharge information communication and prescribing errors: a before and after study
por: Mills, Pamela Ruth, et al.
Publicado: (2017)

Lack of association between proton pump inhibitor use and brain aging: a cross-sectional study
por: Ahn, Nayeon, et al.
Publicado: (2021)

The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations
por: Eriksson, Irene, et al.
Publicado: (2018)

Use of rivaroxaban in Germany: a database drug utilization study of a drug started in hospital
por: Jobski, Kathrin, et al.
Publicado: (2014)

Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee’s list of recommended essential medicines (the ‘Wise List’)
por: Eriksen, Jaran, et al.
Publicado: (2017)

Recognition of adverse drug events in older hospitalized medical patients
por: Klopotowska, Joanna E., et al.
Publicado: (2012)

Medication as a risk factor for hospitalization due to heart failure and shock: a series of case-crossover studies in Swiss claims data
por: Jödicke, Annika M., et al.
Publicado: (2020)

Association between newly initiated thiazide diuretics and hospitalization due to hyponatremia
por: Mannheimer, Buster, et al.
Publicado: (2021)

Outcomes of off-label drug uses in hospitals: a multicentric prospective study
por: Danés, I., et al.
Publicado: (2014)

A survey about label enhancement methods for parenteral medication in European hospital pharmacies
por: Larmené-Beld, K. H. M., et al.
Publicado: (2020)

Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department
por: Kauppila, Mirjam, et al.
Publicado: (2020)

Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention study
por: van Uden, Renate C. A. E., et al.
Publicado: (2021)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study
por: van de Garde, Ewoudt MW, et al.
Publicado: (2007)

Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission
por: Seiberth, Sarah, et al.
Publicado: (2020)

Potentially inappropriate prescribing in older hospitalized Dutch patients according to the STOPP/START criteria v2: a longitudinal study
por: Damoiseaux-Volman, Birgit A., et al.
Publicado: (2020)

Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework
por: Li, Raymond, et al.
Publicado: (2022)

Incidence of hospital contacts with acute kidney injury after initiation of second-generation antipsychotics in older adults: a Danish population-based cohort study
por: Sharon, Reeha, et al.
Publicado: (2022)

A 1-year cross-sectional analysis of non-interventional post-marketing study protocols submitted to the German Federal Institute for Drugs and Medical Devices (BfArM)
por: von Jeinsen, Beatrice K. J. G., et al.
Publicado: (2013)

An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe
por: Ebbers, Hans C., et al.
Publicado: (2015)

Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study
por: Eriksson, Irene, et al.
Publicado: (2017)

Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologists
por: van Hoorn, Camille E., et al.
Publicado: (2020)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010)

The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians
por: Borgsteede, Sander D., et al.
Publicado: (2010)

Defining antimicrobial prescribing quality indicators: what is a new prescription?
por: Boesten, Jos, et al.
Publicado: (2010)

Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Headley, J., et al.
Publicado: (2007)

How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
por: Teichert, Martina, et al.
Publicado: (2007)

Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system
por: van Geffen, E. C. G., et al.
Publicado: (2007)

Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs
por: Uijtendaal, Esther V., et al.
Publicado: (2011)

The use of driving impairing medicines: a European survey
por: Ravera, Silvia, et al.
Publicado: (2009)

Ten years after the Dutch public health campaign on folic acid: the continuing challenge
por: de Walle, Hermien E. K., et al.
Publicado: (2008)

The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports
por: Derijks, Hieronymus J., et al.
Publicado: (2008)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

Pharmacovigilance in children in Camagüey Province, Cuba
por: Bárzaga Arencibia, Z., et al.
Publicado: (2012)

Effects of codeine on pregnancy outcome: results from a large population-based cohort study
por: Nezvalová-Henriksen, Kateřina, et al.
Publicado: (2011)

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
por: Arbouw, Maurits E. L., et al.
Publicado: (2011)

Systematic review of safety in paediatric drug trials published in 2007
por: Nor Aripin, Khairun Nain Bin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b3serimddj00dqmj78f13anvf9